Toll Free: 1-888-928-9744

Global and United States mRNA Vaccines & Therapeutics In-Depth Research Report 2017-2022

Published: Aug 9, 2017 | Pages: 119 | Publisher: US Market Insight (UMI) | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in mRNA Vaccines & Therapeutics industry.

Major Companies

•	Argos Therapeutics (U.S.)
•	AstraZeneca (UK)
•	Bayer AG (Germany)
•	BioNTech (Germany)
•	Boehringer Ingelheim (Germany)
•	CRISPR Therapeutics (Switzerland)
•	CureVac (Germany)
•	ETheRNA immunotherapies (Belgium)
•	Ethris (Germany)
•	GlaxoSmithKline Vaccines (UK)
•	In-Cell-Art (France)
•	Intellia Therapeutics (U.S.)
•	Janssen (Belhium)
•	Kernal Biologics (U.S.)
•	MaxCyte (U.S.)
•	Moderna Therapeutics (U.S.)
•	Novartis (U.S.)
•	PhaseRx (U.S.)
•	Precision NanoSystems (Canada)
•	RaNa Therapeutics (U.S.)

Key Regions

•	North America
•	United States
•	California
•	Texas
•	New York
•	Others
•	Canada
•	Latin America
•	Mexico
•	Brazil
•	Argentina
•	Others
•	Europe
•	Germany
•	United Kingdom
•	France
•	Italy
•	Spain
•	Russia
•	Netherland
•	Others
•	Asia & Pacific
•	China
•	Japan
•	India
•	Korea
•	Australia
•	Southeast Asia
•	Indonesia
•	Thailand
•	Philippines
•	Vietnam
•	Singapore
•	Malaysia
•	Others
•	Africa & Middle East
•	South Africa
•	Egypt
•	Turkey
•	Saudi Arabia
•	Iran
•	Others

Main types of products

mRNA Vaccines & Therapeutics Market, by Cancer Vaccines

•	Standardized preselected
•	Individualized shared antigens
•	Individualized neoantigens

mRNA Vaccines & Therapeutics Market, by Infectious Disease Vaccines

•	Prophylactic vaccines
•	Therapeutic vaccines
•	Synthetic self-amplifying mRNA vaccines for pandemic outbreaks

mRNA Vaccines & Therapeutics Market, by In vivo Therapeutics

•	Therapeutic proteins
•	Therapeutic antibodies

mRNA Vaccines & Therapeutics Market, by Gene Editing

•	Ex vivo gene editing of gene defects
•	In vivo gene editing of gene defects
•	Ex vivo gene editing of autologous and allogeneic T-cells

mRNA Vaccines & Therapeutics Market, by Key Consumers

•	Hospital
•	Clinic
•	Others
 Table of Contents

Global and United States mRNA Vaccines & Therapeutics In-Depth Research Report 2017-2022

Chapter One Global mRNA Vaccines & Therapeutics Market Overview
    1.1 Global mRNA Vaccines & Therapeutics Market Sales Volume Revenue and Price 2012-2017
    1.2 mRNA Vaccines & Therapeutics, by Cancer Vaccines 2012-2017
        1.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines 2012-2017
        1.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines 2012-2017
        1.2.3 Global mRNA Vaccines & Therapeutics Price by Cancer Vaccines 2012-2017
        1.2.4 Standardized preselected
        1.2.5 Individualized shared antigens
        1.2.6 Individualized neoantigens
    1.3 mRNA Vaccines & Therapeutics, by Infectious Disease Vaccines 2012-2017
        1.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines 2012-2017
        1.3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines 2012-2017
        1.3.3 Global mRNA Vaccines & Therapeutics Price by Infectious Disease Vaccines 2012-2017
        1.3.4 Prophylactic vaccines
        1.3.5 Therapeutic vaccines
        1.3.6 Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
    1.4 mRNA Vaccines & Therapeutics, by In vivo Therapeutics 2012-2017
        1.4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics 2012-2017
        1.4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics 2012-2017
        1.4.3 Global mRNA Vaccines & Therapeutics Price by In vivo Therapeutics 2012-2017
        1.4.4 Therapeutic proteins
        1.4.5 Therapeutic antibodies
    1.5 mRNA Vaccines & Therapeutics, by Gene Editing 2012-2017
        1.5.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing 2012-2017
        1.5.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing 2012-2017
        1.5.3 Global mRNA Vaccines & Therapeutics Price by Gene Editing 2012-2017
        1.5.4 Ex vivo gene editing of gene defects
        1.5.5 In vivo gene editing of gene defects
        1.5.6 Ex vivo gene editing of autologous and allogeneic T-cells

Chapter Two United States mRNA Vaccines & Therapeutics Market Overview
    2.1 United States mRNA Vaccines & Therapeutics Market Sales Volume Revenue and Price 2012-2017
    2.2 mRNA Vaccines & Therapeutics, by Cancer Vaccines 2012-2017
        2.2.1 United States mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines 2012-2017
        2.2.2 United States mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines 2012-2017
        2.2.3 United States mRNA Vaccines & Therapeutics Price by Cancer Vaccines 2012-2017
        2.2.4 Standardized preselected
        2.2.5 Individualized shared antigens
        2.2.6 Individualized neoantigens
    2.3 mRNA Vaccines & Therapeutics, by Infectious Disease Vaccines 2012-2017
        2.3.1 United States mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines 2012-2017
        2.3.2 United States mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines 2012-2017
        2.3.3 United States mRNA Vaccines & Therapeutics Price by Infectious Disease Vaccines 2012-2017
        2.3.4 Prophylactic vaccines
        2.3.5 Therapeutic vaccines
        2.3.6 Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
    2.4 mRNA Vaccines & Therapeutics, by In vivo Therapeutics 2012-2017
        2.4.1 United States mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics 2012-2017
        2.4.2 United States mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics 2012-2017
        2.4.3 United States mRNA Vaccines & Therapeutics Price by In vivo Therapeutics 2012-2017
        2.4.4 Therapeutic proteins
        2.4.5 Therapeutic antibodies
    2.5 mRNA Vaccines & Therapeutics, by Gene Editing 2012-2017
        2.5.1 United States mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing 2012-2017
        2.5.2 United States mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing 2012-2017
        2.5.3 United States mRNA Vaccines & Therapeutics Price by Gene Editing 2012-2017
        2.5.4 Ex vivo gene editing of gene defects
        2.5.5 In vivo gene editing of gene defects
        2.5.6 Ex vivo gene editing of autologous and allogeneic T-cells

Chapter Three mRNA Vaccines & Therapeutics by Regions 2012-2017
    3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Regions 2012-2017
    3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions 2012-2017
    3.3 Global mRNA Vaccines & Therapeutics Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global mRNA Vaccines & Therapeutics by Companies 2012-2017
    4.1 Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Companies 2012-2017
    4.2 Global mRNA Vaccines & Therapeutics Revenue Share by Companies 2012-2017
    4.3 Global Top Companies mRNA Vaccines & Therapeutics Key Product Model and Market Performance
    4.4 Global Top Companies mRNA Vaccines & Therapeutics Key Target Consumers and Market Performance

Chapter Five United States mRNA Vaccines & Therapeutics by Companies 2012-2017
    5.1 United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Companies 2012-2017
    5.2 United States mRNA Vaccines & Therapeutics Revenue Share by Companies 2012-2017
    5.3 United States Top Companies mRNA Vaccines & Therapeutics Key Product Model and Market Performance
    5.4 United States Top Companies mRNA Vaccines & Therapeutics Key Target Consumers and Market Performance

Chapter Six Global mRNA Vaccines & Therapeutics by Consumer 2012-2017
    6.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Consumer 2012-2017
    6.2 Hospital
    6.3 Clinic
    6.4 Others
    6.5 Consuming Habit and Preference

Chapter Seven Global mRNA Vaccines & Therapeutics by Consumer 2012-2017
    7.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Consumer 2012-2017
    7.2 Hospital
    7.3 Clinic
    7.4 Others
    7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Argos Therapeutics (U.S.)
        8.1.1 Argos Therapeutics (U.S.) Company Details and Competitors
        8.1.2 Argos Therapeutics (U.S.) Key mRNA Vaccines & Therapeutics Models and Performance
        8.1.3 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.1.4 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.2 AstraZeneca (UK)
        8.2.1 AstraZeneca (UK) Company Details and Competitors
        8.2.2 AstraZeneca (UK) Key mRNA Vaccines & Therapeutics Models and Performance
        8.2.3 AstraZeneca (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.2.4 AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.3 Bayer AG (Germany)
        8.3.1 Bayer AG (Germany) Company Details and Competitors
        8.3.2 Bayer AG (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        8.3.3 Bayer AG (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.3.4 Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.4 BioNTech (Germany)
        8.4.1 BioNTech (Germany) Company Details and Competitors
        8.4.2 BioNTech (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        8.4.3 BioNTech (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.4.4 BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.5 Boehringer Ingelheim (Germany)
        8.5.1 Boehringer Ingelheim (Germany) Company Details and Competitors
        8.5.2 Boehringer Ingelheim (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        8.5.3 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.5.4 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.6 CRISPR Therapeutics (Switzerland)
        8.6.1 CRISPR Therapeutics (Switzerland) Company Details and Competitors
        8.6.2 CRISPR Therapeutics (Switzerland) Key mRNA Vaccines & Therapeutics Models and Performance
        8.6.3 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.6.4 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.7 CureVac (Germany)
        8.7.1 CureVac (Germany) Company Details and Competitors
        8.7.2 CureVac (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        8.7.3 CureVac (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.7.4 CureVac (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.8 ETheRNA immunotherapies (Belgium)
        8.8.1 ETheRNA immunotherapies (Belgium) Company Details and Competitors
        8.8.2 ETheRNA immunotherapies (Belgium) Key mRNA Vaccines & Therapeutics Models and Performance
        8.8.3 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.8.4 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.9 Ethris (Germany)
        8.9.1 Ethris (Germany) Company Details and Competitors
        8.9.2 Ethris (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
        8.9.3 Ethris (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.9.4 Ethris (Germany) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.10 GlaxoSmithKline Vaccines (UK)
        8.10.1 GlaxoSmithKline Vaccines (UK) Company Details and Competitors
        8.10.2 GlaxoSmithKline Vaccines (UK) Key mRNA Vaccines & Therapeutics Models and Performance
        8.10.3 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
        8.10.4 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Volume Revenue Price Cost and Gross Margin
    8.11 In-Cell-Art (France)
    8.12 Intellia Therapeutics (U.S.)
    8.13 Janssen (Belhium)
    8.14 Kernal Biologics (U.S.)
    8.15 MaxCyte (U.S.)
    8.16 Moderna Therapeutics (U.S.)
    8.17 Novartis (U.S.)
    8.18 PhaseRx (U.S.)
    8.19 Precision NanoSystems (Canada)
    8.20 RaNa Therapeutics (U.S.)

Chapter Nine Industry Chain and Supply Chain
    9.1 mRNA Vaccines & Therapeutics Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 mRNA Vaccines & Therapeutics Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global mRNA Vaccines & Therapeutics Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    10.3 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    10.4 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    10.5 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    10.6 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    10.7 Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)

Chapter Eleven United States mRNA Vaccines & Therapeutics Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    11.3 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    11.4 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    11.5 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    11.6 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    11.7 United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
List of Tables and Figures

    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Cancer Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Cancer Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
    Table Top Companies of Standardized preselected mRNA Vaccines & Therapeutics Products List
    Figure Global Standardized preselected mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Individualized shared antigens mRNA Vaccines & Therapeutics Products List
    Figure Global Individualized shared antigens mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Individualized neoantigens mRNA Vaccines & Therapeutics Products List
    Figure Global Individualized neoantigens mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Infectious Disease Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Infectious Disease Vaccines (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
    Table Top Companies of Prophylactic vaccines mRNA Vaccines & Therapeutics Products List
    Figure Global Prophylactic vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Therapeutic vaccines mRNA Vaccines & Therapeutics Products List
    Figure Global Therapeutic vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Synthetic self-amplifying mRNA vaccines for pandemic outbreaks mRNA Vaccines & Therapeutics Products List
    Figure Global Synthetic self-amplifying mRNA vaccines for pandemic outbreaks mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by In vivo Therapeutics (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by In vivo Therapeutics (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
    Table Top Companies of Therapeutic proteins mRNA Vaccines & Therapeutics Products List
    Figure Global Therapeutic proteins mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Therapeutic antibodies mRNA Vaccines & Therapeutics Products List
    Figure Global Therapeutic antibodies mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Gene Editing (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing in 2016
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Gene Editing (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing in 2016
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
    Table Top Companies of Ex vivo gene editing of gene defects mRNA Vaccines & Therapeutics Products List
    Figure Global Ex vivo gene editing of gene defects mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of In vivo gene editing of gene defects mRNA Vaccines & Therapeutics Products List
    Figure Global In vivo gene editing of gene defects mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Ex vivo gene editing of autologous and allogeneic T-cells mRNA Vaccines & Therapeutics Products List
    Figure Global Ex vivo gene editing of autologous and allogeneic T-cells mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Cancer Vaccines (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Cancer Vaccines in 2016
    Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Cancer Vaccines (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Cancer Vaccines in 2016
    Table United States mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
    Table Top Companies of Standardized preselected mRNA Vaccines & Therapeutics Products List
    Figure United States Standardized preselected mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Individualized shared antigens mRNA Vaccines & Therapeutics Products List
    Figure United States Individualized shared antigens mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Individualized neoantigens mRNA Vaccines & Therapeutics Products List
    Figure United States Individualized neoantigens mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Infectious Disease Vaccines (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Infectious Disease Vaccines in 2016
    Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Infectious Disease Vaccines (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Infectious Disease Vaccines in 2016
    Table United States mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
    Table Top Companies of Prophylactic vaccines mRNA Vaccines & Therapeutics Products List
    Figure United States Prophylactic vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Therapeutic vaccines mRNA Vaccines & Therapeutics Products List
    Figure United States Therapeutic vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Synthetic self-amplifying mRNA vaccines for pandemic outbreaks mRNA Vaccines & Therapeutics Products List
    Figure United States Synthetic self-amplifying mRNA vaccines for pandemic outbreaks mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) by In vivo Therapeutics (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Market Share by In vivo Therapeutics in 2016
    Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by In vivo Therapeutics (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by In vivo Therapeutics in 2016
    Table United States mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
    Table Top Companies of Therapeutic proteins mRNA Vaccines & Therapeutics Products List
    Figure United States Therapeutic proteins mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Therapeutic antibodies mRNA Vaccines & Therapeutics Products List
    Figure United States Therapeutic antibodies mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Gene Editing (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Gene Editing in 2016
    Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Gene Editing (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Gene Editing in 2016
    Table United States mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
    Table Top Companies of Ex vivo gene editing of gene defects mRNA Vaccines & Therapeutics Products List
    Figure United States Ex vivo gene editing of gene defects mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of In vivo gene editing of gene defects mRNA Vaccines & Therapeutics Products List
    Figure United States In vivo gene editing of gene defects mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Top Companies of Ex vivo gene editing of autologous and allogeneic T-cells mRNA Vaccines & Therapeutics Products List
    Figure United States Ex vivo gene editing of autologous and allogeneic T-cells mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Share by Regions (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Regions in 2016
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Regions in 2017
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2016
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2017
    Table Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Regions (2012-2017)
    Table North America mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table North America mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Figure North America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Latin America mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Latin America mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Europe mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Figure Europe mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Asia & Pacific mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Asia & Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Africa & Middle East mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2012-2017)
    Table Africa & Middle East mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Volume (K Units) by Major Companies (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Major Companies 2016
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Major Companies 2017
    Table Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Major Companies (2012-2017)
    Table Global mRNA Vaccines & Therapeutics Revenue Market Share by Major Companies (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Major Companies 2016
    Figure Global mRNA Vaccines & Therapeutics Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States mRNA Vaccines & Therapeutics Sales Volume (K Units) by Top Companies (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Top Companies 2016
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share by Top Companies 2017
    Table United States mRNA Vaccines & Therapeutics Revenue (Million USD) by Top Companies (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Revenue Market Share by Top Companies (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Top Companies 2016
    Figure United States mRNA Vaccines & Therapeutics Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) by Consumer (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Consumer (2012-2017)
    Figure Global mRNA Vaccines & Therapeutics Sales Market Share by Consumer in 2016
    Figure Global Hospital mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Clinic mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure Global Others mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) by Consumer (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Consumer (2012-2017)
    Figure United States mRNA Vaccines & Therapeutics Sales Market Share by Consumer in 2016
    Figure United States Hospital mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Clinic mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Figure United States Others mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
    Table Argos Therapeutics (U.S.) Company Details and Competitors
    Table Argos Therapeutics (U.S.) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table AstraZeneca (UK) Company Details and Competitors
    Table AstraZeneca (UK) Key mRNA Vaccines & Therapeutics Models and Performance
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table Bayer AG (Germany) Company Details and Competitors
    Table Bayer AG (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table BioNTech (Germany) Company Details and Competitors
    Table BioNTech (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table Boehringer Ingelheim (Germany) Company Details and Competitors
    Table Boehringer Ingelheim (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table CRISPR Therapeutics (Switzerland) Company Details and Competitors
    Table CRISPR Therapeutics (Switzerland) Key mRNA Vaccines & Therapeutics Models and Performance
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table CureVac (Germany) Company Details and Competitors
    Table CureVac (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table ETheRNA immunotherapies (Belgium) Company Details and Competitors
    Table ETheRNA immunotherapies (Belgium) Key mRNA Vaccines & Therapeutics Models and Performance
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table Ethris (Germany) Company Details and Competitors
    Table Ethris (Germany) Key mRNA Vaccines & Therapeutics Models and Performance
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline Vaccines (UK) Company Details and Competitors
    Table GlaxoSmithKline Vaccines (UK) Key mRNA Vaccines & Therapeutics Models and Performance
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Business SWOT Analysis and Forecast
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Output (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Global (2012-2017)
    Table In-Cell-Art (France) Company Details and Competitors
    Table Intellia Therapeutics (U.S.) Company Details and Competitors
    Table Janssen (Belhium) Company Details and Competitors
    Table Kernal Biologics (U.S.) Company Details and Competitors
    Table MaxCyte (U.S.) Company Details and Competitors
    Table Moderna Therapeutics (U.S.) Company Details and Competitors
    Table Novartis (U.S.) Company Details and Competitors
    Table PhaseRx (U.S.) Company Details and Competitors
    Table Precision NanoSystems (Canada) Company Details and Competitors
    Table RaNa Therapeutics (U.S.) Company Details and Competitors
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Cancer Vaccines in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Infectious Disease Vaccines in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by In vivo Therapeutics in 2022
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Gene Editing in 2022
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    Table United States mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions in 2022
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2022
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Cancer Vaccines (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Cancer Vaccines in 2022
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Infectious Disease Vaccines (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Infectious Disease Vaccines in 2022
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by In vivo Therapeutics (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by In vivo Therapeutics in 2022
    Table United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Gene Editing (2017-2022)
    Figure United States mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Gene Editing in 2022 



                                

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...
Choose License Type
Single User - US $3190
Multi User - US $6380
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: sales@radiantinsights.com

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify